Trials / Unknown
UnknownNCT01620749
Of 18F MEL050 Using PET/CT in Metastatic Melanoma
A Phase 0 Exploratory Microdosing Study of 6-18fluoro-N-[2-(Diethylamino)Ethyl]Pyridine-3-carboxamide (18F MEL050) Using PET/CT in Patients With Metastatic Melanoma
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Cooperative Research Centre for Biomedical Imaging Development · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the safety and potential effectiveness of the imaging compound 18F MEL050 for finding sites of melanoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | 18F MEL050 | Diagnostic intervention to establish the safety and biodistribution of MEL050 in participants with melanoma. |
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2012-03-01
- Completion
- 2012-12-01
- First posted
- 2012-06-15
- Last updated
- 2012-06-15
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT01620749. Inclusion in this directory is not an endorsement.